-
1
-
-
13144285689
-
Blood collection and transfusion in the United States in 1999
-
Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion. 2005 ; 45: 141-148.
-
(2005)
Transfusion
, vol.45
, pp. 141-148
-
-
Sullivan, M.T.1
Wallace, E.L.2
-
2
-
-
0037343942
-
Use of sentinel sites for daily monitoring of the US blood supply
-
Nightingale S, Wanamaker V, Silverman B, et al. Use of sentinel sites for daily monitoring of the US blood supply. Transfusion. 2003 ; 43: 364-372.
-
(2003)
Transfusion
, vol.43
, pp. 364-372
-
-
Nightingale, S.1
Wanamaker, V.2
Silverman, B.3
-
3
-
-
2442481588
-
Transfusion Medicine: Support of patients undergoing cardiac surgery
-
Goodnough LT, Despotis GJ. Transfusion Medicine: support of patients undergoing cardiac surgery. Am J Cardiovasc Drugs. 2001 ; 1: 337-351.
-
(2001)
Am J Cardiovasc Drugs
, vol.1
, pp. 337-351
-
-
Goodnough, L.T.1
Despotis, G.J.2
-
4
-
-
0025972274
-
Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children
-
Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children. Blood. 1991 ; 77: 930-936.
-
(1991)
Blood
, vol.77
, pp. 930-936
-
-
Manno, C.S.1
Hedberg, K.W.2
Kim, H.C.3
-
5
-
-
5344278329
-
Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants
-
Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med. 2004 ; 351: 1635-1644.
-
(2004)
N Engl J Med
, vol.351
, pp. 1635-1644
-
-
Mou, S.S.1
Giroir, B.P.2
Molitor-Kirsch, E.A.3
-
6
-
-
0033014430
-
Factors associated with blood loss and blood product transfusions: A multivariate analysis on children after open-heart surgery
-
Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis on children after open-heart surgery. Anesth Analg. 1999 ; 89: 57-64.
-
(1999)
Anesth Analg
, vol.89
, pp. 57-64
-
-
Williams, G.D.1
Bratton, S.L.2
Ramamoorthy, C.3
-
7
-
-
0032865938
-
Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery
-
Williams GD, Bratton SL, Riley EC, et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1999 ; 13: 398-404.
-
(1999)
J Cardiothorac Vasc Anesth
, vol.13
, pp. 398-404
-
-
Williams, G.D.1
Bratton, S.L.2
Riley, E.C.3
-
8
-
-
33747618377
-
Physiology and techniques of extracorporeal circulation in the Pediatric Patient
-
Lake CL, Booker PD, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins;
-
DiNardo J. Physiology and techniques of extracorporeal circulation in the Pediatric Patient. In: Lake CL, Booker PD, eds. Pediatric Cardiac Anesthesia. 4th ed. Philadelphia: Lippincott Williams & Wilkins ; 2005: 228-252.
-
(2005)
Pediatric Cardiac Anesthesia
, pp. 228-252
-
-
Dinardo, J.1
-
9
-
-
0027275986
-
Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss
-
Boldt J, Knothe C, Zickmann B, et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg. 1993 ; 105: 705-711.
-
(1993)
J Thorac Cardiovasc Surg
, vol.105
, pp. 705-711
-
-
Boldt, J.1
Knothe, C.2
Zickmann, B.3
-
10
-
-
0027241263
-
Aprotinin in pediatric cardiac operations: Platelet function, blood loss and use of homologous blood
-
Boldt J, Knothe C, Zickmann B, et al. Aprotinin in pediatric cardiac operations: platelet function, blood loss and use of homologous blood. Ann Thorac Surg. 1993 ; 55: 1460-1466.
-
(1993)
Ann Thorac Surg
, vol.55
, pp. 1460-1466
-
-
Boldt, J.1
Knothe, C.2
Zickmann, B.3
-
11
-
-
0023608558
-
Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass
-
van Oeveren, W, Jansen NJ, Bidstrup BP, et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987 ; 44: 640-645.
-
(1987)
Ann Thorac Surg
, vol.44
, pp. 640-645
-
-
Van Oeveren, W.1
Jansen, N.J.2
Bidstrup, B.P.3
-
12
-
-
0026792857
-
Maturation of the hemostatic system during childhood
-
Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992 ; 80: 1998-2005.
-
(1992)
Blood
, vol.80
, pp. 1998-2005
-
-
Andrew, M.1
Vegh, P.2
Johnston, M.3
-
13
-
-
0036945831
-
Coagulation abnormalities in patients with cyanotic congenital heart disease
-
Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2002 ; 16: 752-765.
-
(2002)
J Cardiothorac Vasc Anesth
, vol.16
, pp. 752-765
-
-
Tempe, D.K.1
Virmani, S.2
-
14
-
-
0014732565
-
Hemostasis in cyanotic congenital heart disease
-
Ekert H, Gilchrist GS, Stanton R, et al. Hemostasis in cyanotic congenital heart disease. J Pediatr. 1970 ; 76: 221-230.
-
(1970)
J Pediatr
, vol.76
, pp. 221-230
-
-
Ekert, H.1
Gilchrist, G.S.2
Stanton, R.3
-
15
-
-
0026785646
-
Coagulation defects in neonates during cardiopulmonary bypass
-
Kern FH, Morana NJ, Sears JJ, et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg. 1992 ; 54: 541-546.
-
(1992)
Ann Thorac Surg
, vol.54
, pp. 541-546
-
-
Kern, F.H.1
Morana, N.J.2
Sears, J.J.3
-
16
-
-
0026708757
-
Response to heparinization in adults and children undergoing cardiac operations
-
Horkay F, Martin P, Rajah M, et al. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg. 1992 ; 53: 822-826.
-
(1992)
Ann Thorac Surg
, vol.53
, pp. 822-826
-
-
Horkay, F.1
Martin, P.2
Rajah, M.3
-
17
-
-
0028809946
-
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
-
Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 1995 ; 60: 1008-1014.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 1008-1014
-
-
Khuri, S.F.1
Valeri, C.R.2
Loscalzo, J.3
-
18
-
-
0027310437
-
The platelet function defect of cardiopulmonary bypass
-
Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood. 1993 ; 82: 107-117.
-
(1993)
Blood
, vol.82
, pp. 107-117
-
-
Kestin, A.S.1
Valeri, C.R.2
Khuri, S.F.3
-
19
-
-
0345487533
-
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor
-
Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation. 1998 ; 97: 251-256.
-
(1998)
Circulation
, vol.97
, pp. 251-256
-
-
Xiao, Z.1
Theroux, P.2
-
20
-
-
0034124723
-
The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood cytometry
-
Kozek-Langenecker SA, Mohammad SF, Masaki T, et al. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood cytometry. Anesth Analg. 2000 ; 90: 808-812.
-
(2000)
Anesth Analg
, vol.90
, pp. 808-812
-
-
Kozek-Langenecker, S.A.1
Mohammad, S.F.2
Masaki, T.3
-
21
-
-
0033850594
-
The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass
-
Muriithi EW, Belcher PR, Rao JN, et al. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000 ; 120: 538-543.
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 538-543
-
-
Muriithi, E.W.1
Belcher, P.R.2
Rao, J.N.3
-
22
-
-
0033922114
-
Heparin-induced platelet dysfunction and cardiopulmonary bypass
-
Muriithi EW, Belcher PR, Day SP, et al. Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg. 2000 ; 69: 1827-1832.
-
(2000)
Ann Thorac Surg
, vol.69
, pp. 1827-1832
-
-
Muriithi, E.W.1
Belcher, P.R.2
Day, S.P.3
-
23
-
-
0036796602
-
Lipolysis generates platelet dysfunction after in vivo heparin administration
-
Muriithi EW, Belcher PR, Day SP, et al. Lipolysis generates platelet dysfunction after in vivo heparin administration. Clin Sci (Lond). 2002 ; 103: 433-440.
-
(2002)
Clin Sci (Lond)
, vol.103
, pp. 433-440
-
-
Muriithi, E.W.1
Belcher, P.R.2
Day, S.P.3
-
25
-
-
0141453790
-
Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest
-
Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003 ; 21: 527-551.
-
(2003)
Anesthesiol Clin North America
, vol.21
, pp. 527-551
-
-
Green, J.A.1
Spiess, B.D.2
-
26
-
-
0029052424
-
The impact of heparin concentration and activated clotting time monitoring on blood conservation. a prospective, randomized evaluation in patients undergoing cardiac operation
-
Despotis GJ, Joist JH, Hogue CW Jr, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995 ; 110: 46-54.
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 46-54
-
-
Despotis, G.J.1
Joist, J.H.2
Hogue Jr., C.W.3
-
27
-
-
8044257128
-
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT
-
Despotis GJ, Joist JH, Hogue CW Jr, et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996 ; 76: 902-908.
-
(1996)
Thromb Haemost
, vol.76
, pp. 902-908
-
-
Despotis, G.J.1
Joist, J.H.2
Hogue Jr., C.W.3
-
28
-
-
0029075636
-
Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations
-
Jobes DR, Aitken GJ, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995 ; 110: 36-45.
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 36-45
-
-
Jobes, D.R.1
Aitken, G.J.2
Shaffer, G.W.3
-
29
-
-
0030028375
-
Factors associated with excessive post-operative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
-
Despotis GJ, Filos KS, Zoys TN, et al. Factors associated with excessive post-operative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996 ; 82: 13-21.
-
(1996)
Anesth Analg
, vol.82
, pp. 13-21
-
-
Despotis, G.J.1
Filos, K.S.2
Zoys, T.N.3
-
30
-
-
0030948890
-
The effects of heparinase-1 and protamine on platelet reactivity
-
Ammar T, Fisher C. The effects of heparinase-1 and protamine on platelet reactivity. Anesthesiology. 1997 ; 86: 1382-1386.
-
(1997)
Anesthesiology
, vol.86
, pp. 1382-1386
-
-
Ammar, T.1
Fisher, C.2
-
31
-
-
0032775491
-
Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass
-
Shigeta O, Kojima H, Hiramatsu Y, et al. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999 ; 118: 354-360.
-
(1999)
J Thorac Cardiovasc Surg
, vol.118
, pp. 354-360
-
-
Shigeta, O.1
Kojima, H.2
Hiramatsu, Y.3
-
32
-
-
0031687988
-
Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass
-
Mochizuki T, Olson PJ, Szlam F, et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998 ; 87: 781-785.
-
(1998)
Anesth Analg
, vol.87
, pp. 781-785
-
-
Mochizuki, T.1
Olson, P.J.2
Szlam, F.3
-
33
-
-
0028196878
-
Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro
-
Michelson AD, MacGregor H, Barnard MR, et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 1994 ; 71: 633-640.
-
(1994)
Thromb Haemost
, vol.71
, pp. 633-640
-
-
Michelson, A.D.1
MacGregor, H.2
Barnard, M.R.3
-
34
-
-
0026695183
-
Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass
-
Valeri CR, Khabbaz K, Khuri SF, et al. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg. 1992 ; 104: 108-116.
-
(1992)
J Thorac Cardiovasc Surg
, vol.104
, pp. 108-116
-
-
Valeri, C.R.1
Khabbaz, K.2
Khuri, S.F.3
-
35
-
-
0030200372
-
Normothermic versus hypothermic cardiopulmonary bypass: Do changes in coagulation differ?
-
Boldt J, Knothe C, Welters I, et al. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ? Ann Thorac Surg. 1996 ; 62: 130-135.
-
(1996)
Ann Thorac Surg
, vol.62
, pp. 130-135
-
-
Boldt, J.1
Knothe, C.2
Welters, I.3
-
36
-
-
0029078918
-
Platelet activation in warm and cold heart surgery
-
Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg. 1995 ; 59: 1481-1486.
-
(1995)
Ann Thorac Surg
, vol.59
, pp. 1481-1486
-
-
Mazer, C.D.1
Hornstein, A.2
Freedman, J.3
-
37
-
-
28144443221
-
Sustained hypothermia accelerates microvascular thrombus formation in mice
-
Lindenblatt N, Menger MD, Klar E, et al. Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol (Heart Circ Physiol). 2005 ; 289: H2680 - H2687.
-
(2005)
Am J Physiol (Heart Circ Physiol)
, vol.289
-
-
Lindenblatt, N.1
Menger, M.D.2
Klar, E.3
-
38
-
-
0031749074
-
In vitro hypothermia enhances platelet GPIIb/IIIa activation and P-selectin expression
-
Faraday N, Rosenfeld BA. In vitro hypothermia enhances platelet GPIIb/IIIa activation and P-selectin expression. Anesthesiology. 1998 ; 88: 1579-1585.
-
(1998)
Anesthesiology
, vol.88
, pp. 1579-1585
-
-
Faraday, N.1
Rosenfeld, B.A.2
-
39
-
-
0036134077
-
Hypothermiainduced platelet aggregation in heparinized flowing human blood: Identification of a high responder subpopulation
-
Hall MW, Goodman PD, Alston SM, et al. Hypothermiainduced platelet aggregation in heparinized flowing human blood: identification of a high responder subpopulation. Am J Hematology. 2002 ; 69: 45-55.
-
(2002)
Am J Hematology
, vol.69
, pp. 45-55
-
-
Hall, M.W.1
Goodman, P.D.2
Alston, S.M.3
-
40
-
-
22144492951
-
Hypothermiainduced platelet aggregation and cognitive decline in coronary artery bypass surgery: A pilot study
-
Hall MW, Hopkins RO, Long JW, et al. Hypothermiainduced platelet aggregation and cognitive decline in coronary artery bypass surgery: a pilot study. Perfusion. 2005 ; 20: 157-167.
-
(2005)
Perfusion
, vol.20
, pp. 157-167
-
-
Hall, M.W.1
Hopkins, R.O.2
Long, J.W.3
-
41
-
-
21344435080
-
Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?
-
Fergusson D, Glass KC, Hutton B, et al. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? Clin Trials. 2005 ; 2: 218-232.
-
(2005)
Clin Trials
, vol.2
, pp. 218-232
-
-
Fergusson, D.1
Glass, K.C.2
Hutton, B.3
-
42
-
-
0031415922
-
Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analysis using perioperative blood transfusion as the outcome
-
Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analysis using perioperative blood transfusion as the outcome. Anesth Analg. 1997 ; 85: 1258-1267.
-
(1997)
Anesth Analg
, vol.85
, pp. 1258-1267
-
-
Laupacis, A.1
Fergusson, D.2
-
43
-
-
0031437079
-
Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: A randomized, blinded clinical trial
-
Bennett-Guerrero E, Sorohan JG, Gurevich ML, et al. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial. Anesthesiology. 1997 ; 87: 1373-1380.
-
(1997)
Anesthesiology
, vol.87
, pp. 1373-1380
-
-
Bennett-Guerrero, E.1
Sorohan, J.G.2
Gurevich, M.L.3
-
44
-
-
10244240505
-
Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid
-
Vander Salm TJ, Kaur S, Lancey RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg. 1996 ; 112: 1098-1107.
-
(1996)
J Thorac Cardiovasc Surg
, vol.112
, pp. 1098-1107
-
-
Vander Salm, T.J.1
Kaur, S.2
Lancey, R.A.3
-
45
-
-
4444380033
-
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
-
Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004 ; 128: 442-448.
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 442-448
-
-
Sedrakyan, A.1
Treasure, T.2
Elefteriades, J.A.3
-
46
-
-
0033862187
-
The antithrombotic effect of aprotinin: Actions mediated via the protease-activated receptor-1
-
Poullis M, Manning R, Laffan M, et al. The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor-1. J Thorac Cardiovasc Surg. 2000 ; 120: 370-378.
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 370-378
-
-
Poullis, M.1
Manning, R.2
Laffan, M.3
-
47
-
-
0035163406
-
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
-
Despotis GJ, Avidan MS, Hogue Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001 ; 72: S1821 - S1831.
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Despotis, G.J.1
Avidan, M.S.2
Hogue, Jr.3
-
48
-
-
0032178036
-
Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest
-
Eaton MP, Deeb GM. Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 1998 ; 12: 548-552.
-
(1998)
J Cardiothorac Vasc Anesth
, vol.12
, pp. 548-552
-
-
Eaton, M.P.1
Deeb, G.M.2
-
49
-
-
24644517175
-
Pharmacologic cerebral capillary blood flow improvement after deep hypothermic circulatory arrest: An intravital fluorescence microscopy study in pigs
-
Ben Mime L, Arnhold S, Fischer JH, et al. Pharmacologic cerebral capillary blood flow improvement after deep hypothermic circulatory arrest: an intravital fluorescence microscopy study in pigs. J Thorac Cardiovasc Surg. 2005 ; 130: 670-676.
-
(2005)
J Thorac Cardiovasc Surg
, vol.130
, pp. 670-676
-
-
Ben Mime, L.1
Arnhold, S.2
Fischer, J.H.3
-
50
-
-
22144486965
-
Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest
-
Straub A, Azevedo R, Beierlein W, et al. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost. 2005 ; 94: 115-122.
-
(2005)
Thromb Haemost
, vol.94
, pp. 115-122
-
-
Straub, A.1
Azevedo, R.2
Beierlein, W.3
-
51
-
-
17444367990
-
Hypothermiainduced platelet aggregation: No effect of aprotinin (trasylol) but inhibition by eptifibatide (integrelin)
-
Straub A, Azevedo R, Beierlein W, et al. Hypothermiainduced platelet aggregation: no effect of aprotinin (trasylol) but inhibition by eptifibatide (integrelin). Thorac Cardiovasc Surg. 2005 ; 53: 80-84.
-
(2005)
Thorac Cardiovasc Surg
, vol.53
, pp. 80-84
-
-
Straub, A.1
Azevedo, R.2
Beierlein, W.3
-
52
-
-
0033932191
-
Use of recombinant-hirudin in pulmonary thromboendarterectomy
-
Rubens, FD, Sabloff M, Wells PS, et al. Use of recombinant-hirudin in pulmonary thromboendarterectomy. Ann Thorac Surg. 2000 ; 69: 1942-1943.
-
(2000)
Ann Thorac Surg
, vol.69
, pp. 1942-1943
-
-
Rubens, F.D.1
Sabloff, M.2
Wells, P.S.3
-
53
-
-
0036259197
-
Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: A pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia
-
Koster A, Sanger S, Knorig J, et al. Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J. 2002 ; 48: 106-109.
-
(2002)
ASAIO J
, vol.48
, pp. 106-109
-
-
Koster, A.1
Sanger, S.2
Knorig, J.3
-
54
-
-
0342953146
-
Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage
-
Mossinger H, Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg. 1998 ; 65 (6 suppl). S45 - S50.
-
(1998)
Ann Thorac Surg
, vol.65
, Issue.6 SUPPL.
-
-
Mossinger, H.1
Dietrich, W.2
-
55
-
-
0031057652
-
Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass
-
Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost. 1997 ; 77: 270-277.
-
(1997)
Thromb Haemost
, vol.77
, pp. 270-277
-
-
Chan, A.K.1
Leaker, M.2
Burrows, F.A.3
-
56
-
-
0018655358
-
Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children
-
Pang LM, Stalcup SA, Lipset JS, et al. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children. Circulation. 1979 ; 60: 1503-1507.
-
(1979)
Circulation
, vol.60
, pp. 1503-1507
-
-
Pang, L.M.1
Stalcup, S.A.2
Lipset, J.S.3
-
57
-
-
0032776365
-
Aprotinin in deep hypothermic circulatory arrest
-
Smith CR, Spanier TB. Aprotinin in deep hypothermic circulatory arrest. Ann Thorac Surg. 1999 ; 68: 278-286.
-
(1999)
Ann Thorac Surg
, vol.68
, pp. 278-286
-
-
Smith, C.R.1
Spanier, T.B.2
-
58
-
-
0012541372
-
Transfusion medicine and coagulation disorders
-
Kaplan JA, ed. Philadelphia: WB Saunders;
-
Horrow J. Transfusion medicine and coagulation disorders. In: Kaplan JA, ed. Cardiac Anesthesia. Philadelphia: WB Saunders ; 1987: 111-1154.
-
(1987)
Cardiac Anesthesia
, pp. 111-1154
-
-
Horrow, J.1
-
59
-
-
0016590629
-
Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery
-
Nagaoka H, Katori M. Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery. Circulation. 1975 ; 52: 325-332.
-
(1975)
Circulation
, vol.52
, pp. 325-332
-
-
Nagaoka, H.1
Katori, M.2
-
60
-
-
0025992843
-
Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass
-
Blauhut B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991 ; 101: 958-967.
-
(1991)
J Thorac Cardiovasc Surg
, vol.101
, pp. 958-967
-
-
Blauhut, B.1
Gross, C.2
Necek, S.3
-
61
-
-
0028317074
-
Aprotinin effect on platelet function and clotting during cardiopulmonary bypass
-
Tabuchi N, DeHann J, Boonstra PW, et al. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. Eur J Cardiothorac Surg. 1994 ; 8: 87-90, 1994
-
(1994)
Eur J Cardiothorac Surg
, vol.8
, pp. 87-90
-
-
Tabuchi, N.1
Dehann, J.2
Boonstra, P.W.3
-
62
-
-
0027216882
-
Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery
-
Huang H, Ding W, Su Z, et al. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg. 1993 ; 106: 11-18.
-
(1993)
J Thorac Cardiovasc Surg
, vol.106
, pp. 11-18
-
-
Huang, H.1
Ding, W.2
Su, Z.3
-
63
-
-
0030791587
-
Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass
-
Shigeta O, Kojima H, Jikuya T, et al. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass. Circulation. 1997 ; 96: 569-574.
-
(1997)
Circulation
, vol.96
, pp. 569-574
-
-
Shigeta, O.1
Kojima, H.2
Jikuya, T.3
-
64
-
-
0030060802
-
Reducing thrombin formation during cardiopulmonary bypass: Is there a benefit of the additional anticoagulant action of aprotinin?
-
Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin? J Cardiovasc Pharmacol. 1996 ; 27 (suppl 1). S50 - S57.
-
(1996)
J Cardiovasc Pharmacol
, vol.27
, Issue.SUPPL. 1
-
-
Dietrich, W.1
-
65
-
-
0027243485
-
Reduction of heparin binding to and inhibition of platelets by aprotinin
-
John LC, Rees GM, Kovacs IB. Reduction of heparin binding to and inhibition of platelets by aprotinin. Ann Thorac Surg. 1993 ; 55: 1175-1179.
-
(1993)
Ann Thorac Surg
, vol.55
, pp. 1175-1179
-
-
John, L.C.1
Rees, G.M.2
Kovacs, I.B.3
-
66
-
-
0035656032
-
The antithrombotic and antiinflammatory mechanisms of action of aprotinin
-
Landis RC, Asimakopoulos G, Poullis M, et al. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg. 2001 ; 72: 2169-2175.
-
(2001)
Ann Thorac Surg
, vol.72
, pp. 2169-2175
-
-
Landis, R.C.1
Asimakopoulos, G.2
Poullis, M.3
-
67
-
-
0035171791
-
New antiinflammatory and platelet-preserving effects of aprotinin
-
Landis RC, Haskard DO, Taylor KM. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg. 2001 ; 72: S1808 - S1813.
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Landis, R.C.1
Haskard, D.O.2
Taylor, K.M.3
-
68
-
-
0025142843
-
Aprotinin in pediatric cardiac surgery
-
Elliott MJ, Allen A. Aprotinin in pediatric cardiac surgery. Perfusion. 1990 ; 5: 73-76.
-
(1990)
Perfusion
, vol.5
, pp. 73-76
-
-
Elliott, M.J.1
Allen, A.2
-
69
-
-
0007636102
-
Studies on the cause of bleeding during and after surgery with heart-lung-machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment
-
McConn R, ed. New York: Raven;
-
Popov-Cenic S, Urban AE, Noe G. Studies on the cause of bleeding during and after surgery with heart-lung-machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment. In: McConn R, ed. Role of Chemical Mediators in the Pathophysiology of Acute Illness Injury. New York: Raven ; 1982: 229-242.
-
(1982)
Role of Chemical Mediators in the Pathophysiology of Acute Illness Injury
, pp. 229-242
-
-
Popov-Cenic, S.1
Urban, A.E.2
Noe, G.3
-
70
-
-
0029436203
-
Aprotinin in children undergoing repair of congenital heart defects
-
Penkoske PA, Entwistle LM, Marchak BE, et al. Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac Surg. 1995 ; 60: S529 - S532.
-
(1995)
Ann Thorac Surg
, vol.60
-
-
Penkoske, P.A.1
Entwistle, L.M.2
Marchak, B.E.3
-
71
-
-
0035114126
-
Pro. Aprotinin should be used in patients undergoing hypothermic circulatory arrest
-
Royston D. Pro. Aprotinin should be used in patients undergoing hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 2001 ; 15: 121-125.
-
(2001)
J Cardiothorac Vasc Anesth
, vol.15
, pp. 121-125
-
-
Royston, D.1
-
72
-
-
0037314646
-
High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery
-
Mossinger H, Dietrich W, Braun SL, et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg. 2003 ; 75: 430-437.
-
(2003)
Ann Thorac Surg
, vol.75
, pp. 430-437
-
-
Mossinger, H.1
Dietrich, W.2
Braun, S.L.3
-
73
-
-
0027173089
-
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations
-
Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg. 1993 ; 105: 712-720.
-
(1993)
J Thorac Cardiovasc Surg
, vol.105
, pp. 712-720
-
-
Dietrich, W.1
Mossinger, H.2
Spannagl, M.3
-
74
-
-
2642580925
-
Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery
-
Oliver WC, Fass DN, Nuttall GA, et al. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2004 ; 127: 1670-1677.
-
(2004)
J Thorac Cardiovasc Surg
, vol.127
, pp. 1670-1677
-
-
Oliver, W.C.1
Fass, D.N.2
Nuttall, G.A.3
-
75
-
-
6844234430
-
Influence of aprotinin on coagulation patterns and blood loss in infants undergoing surgery for congenital heart defects [abstract]
-
Mossinger HD, Spannagel M. Influence of aprotinin on coagulation patterns and blood loss in infants undergoing surgery for congenital heart defects [abstract]. Anesthesiology. 1991 ; 75: A77 - A77.
-
(1991)
Anesthesiology
, vol.75
-
-
Mossinger, H.D.1
Spannagel, M.2
-
76
-
-
0037167689
-
Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients
-
Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002 ; 106 (12 suppl 1). I82 - I89.
-
(2002)
Circulation
, vol.106
, Issue.12 SUPPL. 1
-
-
Tweddell, J.S.1
Hoffman, G.M.2
Mussatto, K.A.3
-
77
-
-
0037385540
-
Aprotinin reduces operative closure time and blood product use after pediatric bypass
-
Costello JM, Backer CL, deHoyos A, et al. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg. 2003 ; 75: 1261-1266.
-
(2003)
Ann Thorac Surg
, vol.75
, pp. 1261-1266
-
-
Costello, J.M.1
Backer, C.L.2
Dehoyos, A.3
-
78
-
-
0029958434
-
The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery
-
D'Errico CC, Shayevitz JR, Martindale SJ, et al. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg. 1996 ; 83: 1193-1199.
-
(1996)
Anesth Analg
, vol.83
, pp. 1193-1199
-
-
D'Errico, C.C.1
Shayevitz, J.R.2
Martindale, S.J.3
-
79
-
-
0031802907
-
Pharmacoeconomics analysis in a pediatric population
-
D'Errico CC. Pharmacoeconomics analysis in a pediatric population. Ann Thorac Surg. 1998 ; 65 (6 suppl). S52 - S54.
-
(1998)
Ann Thorac Surg
, vol.65
, Issue.6 SUPPL.
-
-
D'Errico, C.C.1
-
80
-
-
0028093457
-
Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest
-
Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994 ; 58: 146-153.
-
(1994)
Ann Thorac Surg
, vol.58
, pp. 146-153
-
-
Aoki, M.1
Jonas, R.A.2
Nomura, F.3
-
81
-
-
31344467254
-
The risk associated with aprotinin in cardiac surgery
-
Mangano DT, Tudor IC, Dietzel C, et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006 ; 354: 353-365.
-
(2006)
N Engl J Med
, vol.354
, pp. 353-365
-
-
Mangano, D.T.1
Tudor, I.C.2
Dietzel, C.3
-
82
-
-
0035908943
-
Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest
-
Mora Mangano CT, Neville MJ, Hsu PH, et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation. 2001 ; 104 (12 suppl 1). I276 - I281.
-
(2001)
Circulation
, vol.104
, Issue.12 SUPPL. 1
-
-
Mora Mangano, C.T.1
Neville, M.J.2
Ph, H.3
-
83
-
-
4444380033
-
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
-
Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004 ; 128: 442-448.
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 442-448
-
-
Sedrakyan, A.1
Treasure, T.2
Elefteriades, J.A.3
-
84
-
-
0031802754
-
Review of efficacy parameters
-
Pouard P. Review of efficacy parameters. Ann Thorac Surg. 1998 ; 65 (suppl 6). S40 - S43.
-
(1998)
Ann Thorac Surg
, vol.65
, Issue.SUPPL. 6
-
-
Pouard, P.1
-
85
-
-
0031030981
-
Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations
-
Dietrich W, Spath P, Ebell A, et al. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg. 1997 ; 113: 194-201.
-
(1997)
J Thorac Cardiovasc Surg
, vol.113
, pp. 194-201
-
-
Dietrich, W.1
Spath, P.2
Ebell, A.3
-
86
-
-
0037167647
-
Safety of aprotinin use and re-use in pediatric cardiothoracic surgery
-
Jaquiss RD, Ghanayem NS, Zacharisen MC, et al. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation. 2002 ; 106 (12 suppl 1). I90 - I94.
-
(2002)
Circulation
, vol.106
, Issue.12 SUPPL. 1
-
-
Jaquiss, R.D.1
Ghanayem, N.S.2
Zacharisen, M.C.3
-
88
-
-
0034668795
-
Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system
-
Ries M, Zenker M, Gaffney PJ. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. Thromb Res. 2000 ; 100: 341-351.
-
(2000)
Thromb Res
, vol.100
, pp. 341-351
-
-
Ries, M.1
Zenker, M.2
Gaffney, P.J.3
-
89
-
-
0033787561
-
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease
-
Chauhan S, Kumar BA, Rao BH, et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg. 2000 ; 70: 1308-1312.
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1308-1312
-
-
Chauhan, S.1
Kumar, B.A.2
Rao, B.H.3
-
90
-
-
13244295652
-
Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination?
-
Bulutcu FS, Ozbek U, Polat B, et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth. 2005 ; 15: 41-46.
-
(2005)
Paediatr Anaesth
, vol.15
, pp. 41-46
-
-
Bulutcu, F.S.1
Ozbek, U.2
Polat, B.3
-
91
-
-
1942423177
-
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery
-
Chauhan S, Das SN, Bisoi A, et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2004 ; 18: 141-143.
-
(2004)
J Cardiothorac Vasc Anesth
, vol.18
, pp. 141-143
-
-
Chauhan, S.1
Das, S.N.2
Bisoi, A.3
-
92
-
-
0030950836
-
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery
-
Reid RW, Zimmerman AA, Laussen PC, et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg. 1997 ; 84: 990-996.
-
(1997)
Anesth Analg
, vol.84
, pp. 990-996
-
-
Reid, R.W.1
Zimmerman, A.A.2
Laussen, P.C.3
-
93
-
-
0034047255
-
Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure
-
Gruber EM, Shukla AC, Reid RW, et al. Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure. J Cardiothorac Vasc Anesth. 2000 ; 14: 257-259.
-
(2000)
J Cardiothorac Vasc Anesth
, vol.14
, pp. 257-259
-
-
Gruber, E.M.1
Shukla, A.C.2
Reid, R.W.3
-
94
-
-
0025269232
-
Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation
-
Andersson TLG, Solem JO, Tengborn L, et al. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation. 1990 ; 81: 872-878.
-
(1990)
Circulation
, vol.81
, pp. 872-878
-
-
Tlg, A.1
Solem, J.O.2
Tengborn, L.3
-
95
-
-
0028885045
-
The effect of desmopressin on reducing blood loss in cardiac surgery - A meta-analysis of double-blind, placebo-controlled trials
-
Cattaneo M, Harris AS, Stromberg U, et al. The effect of desmopressin on reducing blood loss in cardiac surgery - a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost. 1995 ; 74: 1064-1070.
-
(1995)
Thromb Haemost
, vol.74
, pp. 1064-1070
-
-
Cattaneo, M.1
Harris, A.S.2
Stromberg, U.3
-
96
-
-
0034528784
-
Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations
-
Oliver WC, Santrach PJ, Danielson GK, et al. Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Ann Thorac Surg. 2000 ; 70: 1923-1930.
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1923-1930
-
-
Oliver, W.C.1
Santrach, P.J.2
Danielson, G.K.3
-
97
-
-
14944387143
-
Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease
-
Razon Y, Erez E, Vidne B, et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth. 2005 ; 15: 235-240.
-
(2005)
Paediatr Anaesth
, vol.15
, pp. 235-240
-
-
Razon, Y.1
Erez, E.2
Vidne, B.3
-
98
-
-
16544374365
-
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients
-
Tobias JD, Simsic JM, Weinstein S, et al. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med. 2004 ; 19: 270-273.
-
(2004)
J Intensive Care Med
, vol.19
, pp. 270-273
-
-
Tobias, J.D.1
Simsic, J.M.2
Weinstein, S.3
-
99
-
-
22144466560
-
Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery
-
Wittenstein B, Ng C, Ravn H, et al. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med. 2005 ; 6: 473-476.
-
(2005)
Pediatr Crit Care Med
, vol.6
, pp. 473-476
-
-
Wittenstein, B.1
Ng, C.2
Ravn, H.3
-
100
-
-
12544249629
-
Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis
-
Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion. 2005 ; 45: 26-34.
-
(2005)
Transfusion
, vol.45
, pp. 26-34
-
-
Karkouti, K.1
Beattie, W.S.2
Wijeysundera, D.N.3
-
101
-
-
0036241743
-
Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
-
Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg. 2002 ; 94: 1369-1371.
-
(2002)
Anesth Analg
, vol.94
, pp. 1369-1371
-
-
Dietrich, W.1
Spannagl, M.2
|